Your account is not claimed yet. You can sign up with ORCID to claim your account.

Günter Bernhardt

ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 4

Top Venues

European journal of immunology

The Journal of experimental medicine

Nature communications

Hannover Medical School

Ludwig-Maximilians-Universitat Munchen (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hannover Medical School Jan 1o 2002

Germany

Principal investigator :: Institute of Immunology

Education History

Ludwig-Maximilians-Universitat Munchen

Germany

PHD :: Institute of Biochemistry

Publications

Toshiki Yamada, Megumi Tatematsu, Shunsuke Takasuga, Akane Fuchimukai, Kenki Yamagata, Shinsuke Seki, Keiji Kuba, Hideyuki Yoshida, Ichiro Taniuchi, Günter Bernhardt, Kazuko Shibuya, Akira Shibuya, Takechiyo Yamada, Takashi Ebihara
TIGIT mediates activation-induced cell death of ILC2s during chronic airway allergy. The Journal of experimental medicine 220 (7) (2023)
Georg Martin Norbert Behrens, Joana Barros-Martins, Anne Cossmann, Gema Morillas Ramos, Metodi V Stankov, Ivan Odak, Alexandra Dopfer-Jablonka, Laura Hetzel, Miriam Köhler, Gwendolyn Patzer, Christoph Binz, Christiane Ritter, Michaela Friedrichsen, Christian R Schultze-Florey, Inga Ravens, Stefanie Willenzon, Anja Bubke, Jasmin Ristenpart, Anika Janssen, George Liam Ssebyatika, Verena Krähling, Günter Bernhardt, Markus Hoffmann, Stefan Pöhlmann, Thomas Krey, Berislav Bosnjak, Swantje I Hammerschmidt, Reinhold Förster
BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19. Nature communications 13 (1) (2022)
Swantje I Hammerschmidt, Christoph Thurm, Berislav Bošnjak, Günter Bernhardt, Annegret Reinhold, Stefanie Willenzon, Christiane Ritter, Dirk Reinhold, Burkhart Schraven, Reinhold Förster
Robust induction of neutralizing antibodies against the SARS-CoV-2 Delta variant after homologous Spikevax or heterologous Vaxzevria-Spikevax vaccination. European journal of immunology (2021)
Hristo Georgiev, Inga Ravens, Georgia Papadogianni, Bernard Malissen, Reinhold Förster, Günter Bernhardt
Blocking the ART2.2/P2X7-system is essential to avoid a detrimental bias in functional CD4 T cell studies. European journal of immunology 48 (6) (2018)

Günter Bernhardt.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Günter Bernhardt